<!DOCTYPE html>
<html lang="zh-cn">
  <head><script src="/livereload.js?mindelay=10&amp;v=2&amp;port=1313&amp;path=livereload" data-no-instant defer></script>
    <meta charset="utf-8">
    <meta http-equiv="X-UA-Compatible" content="IE=edge,chrome=1">
    
    <title>雷德·霍夫曼为AI抗癌初创公司募资2460万美元。 | AI内参</title>
    <meta name="viewport" content="width=device-width,minimum-scale=1">
    <meta name="description" content="雷德·霍夫曼为AI抗癌初创公司募资2460万美元。">
    <meta name="generator" content="Hugo 0.147.8">
    
    
    
      <meta name="robots" content="noindex, nofollow">
    
    <meta name="author" content="AI News Assistant">
    

    


<link rel="stylesheet" href="/ananke/css/main.min.css" >



<link rel="stylesheet" href="/css/social-share.css">



  
    <link rel="stylesheet" href="/css/custom.css">
  

  
    <link rel="stylesheet" href="/css/article-enhancements.css">
  

    

<script src="/js/social-share.js"></script>



    
      

    

    

    
      <link rel="canonical" href="http://192.168.50.247:1313/insights/2025-06-09-article-446/">
    

    <meta property="og:url" content="http://192.168.50.247:1313/insights/2025-06-09-article-446/">
  <meta property="og:site_name" content="AI内参">
  <meta property="og:title" content="雷德·霍夫曼为AI抗癌初创公司募资2460万美元。">
  <meta property="og:description" content="雷德·霍夫曼为AI抗癌初创公司募资2460万美元。">
  <meta property="og:locale" content="zh_cn">
  <meta property="og:type" content="article">
    <meta property="article:section" content="insights">
    <meta property="article:published_time" content="2025-06-09T00:03:16+00:00">
    <meta property="article:modified_time" content="2025-06-09T00:03:16+00:00">
    <meta property="article:tag" content="AI">
    <meta property="article:tag" content="Technology">

  <meta itemprop="name" content="雷德·霍夫曼为AI抗癌初创公司募资2460万美元。">
  <meta itemprop="description" content="雷德·霍夫曼为AI抗癌初创公司募资2460万美元。">
  <meta itemprop="datePublished" content="2025-06-09T00:03:16+00:00">
  <meta itemprop="dateModified" content="2025-06-09T00:03:16+00:00">
  <meta itemprop="wordCount" content="147">
  <meta itemprop="keywords" content="AI,Technology">
  <meta name="twitter:card" content="summary">
  <meta name="twitter:title" content="雷德·霍夫曼为AI抗癌初创公司募资2460万美元。">
  <meta name="twitter:description" content="雷德·霍夫曼为AI抗癌初创公司募资2460万美元。">

	
  </head><body class="ma0 avenir bg-near-white development">

    
  
  

  <header>
    <div class="bg-black">
      <nav class="pv3 ph3 ph4-ns" role="navigation">
  <div class="flex-l center items-center justify-between">
    <a href="/" class="f3 fw2 hover-white white-90 dib no-underline">
      
        <img src="/logo/logo.png" class="w100 mw5-ns" alt="AI内参" />
      
    </a>
    <div class="flex-l items-center">
      

      
        <ul class="pl0 mr3">
          
          <li class="list f5 f4-ns fw4 dib pr3">
            <a class="hover-white white-90 no-underline" href="/" title="">
              首页
            </a>
          </li>
          
          <li class="list f5 f4-ns fw4 dib pr3">
            <a class="hover-white white-90 no-underline" href="/insights/" title="">
              洞察
            </a>
          </li>
          
          <li class="list f5 f4-ns fw4 dib pr3">
            <a class="hover-white white-90 no-underline" href="/morningnews/" title="">
              早报
            </a>
          </li>
          
          <li class="list f5 f4-ns fw4 dib pr3">
            <a class="hover-white white-90 no-underline" href="/newspaper/" title="">
              日报
            </a>
          </li>
          
          <li class="list f5 f4-ns fw4 dib pr3">
            <a class="hover-white white-90 no-underline" href="/explore/" title="">
              主题探索
            </a>
          </li>
          
          <li class="list f5 f4-ns fw4 dib pr3">
            <a class="hover-white white-90 no-underline" href="/about/" title="">
              关于
            </a>
          </li>
          
        </ul>
      
      <div class="ananke-socials"></div>

    </div>
  </div>
</nav>

    </div>
  </header>



    <main class="pb7" role="main">
      
  
  
  <article class="flex-l mw8 center ph3 flex-wrap justify-between">
    <header class="mt4 w-100">
      <aside class="instapaper_ignoref helvetica tracked">
        <span style="color: #999;">2025-06-09 00:03</span>
      </aside><div id="sharing" class="mt3 ananke-socials"><a href="https://twitter.com/intent/tweet/?text=%E9%9B%B7%E5%BE%B7%C2%B7%E9%9C%8D%E5%A4%AB%E6%9B%BC%E4%B8%BAAI%E6%8A%97%E7%99%8C%E5%88%9D%E5%88%9B%E5%85%AC%E5%8F%B8%E5%8B%9F%E8%B5%842460%E4%B8%87%E7%BE%8E%E5%85%83%E3%80%82%20-%20%E9%9B%B7%E5%BE%B7%C2%B7%E9%9C%8D%E5%A4%AB%E6%9B%BC%E4%B8%BAAI%E6%8A%97%E7%99%8C%E5%88%9D%E5%88%9B%E5%85%AC%E5%8F%B8%E5%8B%9F%E8%B5%842460%E4%B8%87%E7%BE%8E%E5%85%83%E3%80%82&amp;amp;url=http%3A%2F%2F192.168.50.247%3A1313%2Finsights%2F2025-06-09-article-446%2F"
          class="ananke-social-link x-twitter no-underline"
          title="Share on X" aria-label="Share on X"
          target="_blank" rel="nofollow noopener noreferrer"><span class="icon">
                <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Free 6.6.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2024 Fonticons, Inc. --><path d="M389.2 48h70.6L305.6 224.2 487 464H345L233.7 318.6 106.5 464H35.8L200.7 275.5 26.8 48H172.4L272.9 180.9 389.2 48zM364.4 421.8h39.1L151.1 88h-42L364.4 421.8z"/></svg>
                
              </span></a><a href="http://service.weibo.com/share/share.php?title=%E9%9B%B7%E5%BE%B7%C2%B7%E9%9C%8D%E5%A4%AB%E6%9B%BC%E4%B8%BAAI%E6%8A%97%E7%99%8C%E5%88%9D%E5%88%9B%E5%85%AC%E5%8F%B8%E5%8B%9F%E8%B5%842460%E4%B8%87%E7%BE%8E%E5%85%83%E3%80%82%20-%20%E9%9B%B7%E5%BE%B7%C2%B7%E9%9C%8D%E5%A4%AB%E6%9B%BC%E4%B8%BAAI%E6%8A%97%E7%99%8C%E5%88%9D%E5%88%9B%E5%85%AC%E5%8F%B8%E5%8B%9F%E8%B5%842460%E4%B8%87%E7%BE%8E%E5%85%83%E3%80%82&amp;amp;url=http%3A%2F%2F192.168.50.247%3A1313%2Finsights%2F2025-06-09-article-446%2F"
          class="ananke-social-link weibo no-underline"
          title="Share on Weibo" aria-label="Share on Weibo"
          target="_blank" rel="nofollow noopener noreferrer"><span class="icon">
                <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 512 512"><!--! Font Awesome Free 6.6.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2024 Fonticons, Inc. --><path d="M407 177.6c7.6-24-13.4-46.8-37.4-41.7-22 4.8-28.8-28.1-7.1-32.8 50.1-10.9 92.3 37.1 76.5 84.8-6.8 21.2-38.8 10.8-32-10.3zM214.8 446.7C108.5 446.7 0 395.3 0 310.4c0-44.3 28-95.4 76.3-143.7C176 67 279.5 65.8 249.9 161c-4 13.1 12.3 5.7 12.3 6 79.5-33.6 140.5-16.8 114 51.4-3.7 9.4 1.1 10.9 8.3 13.1 135.7 42.3 34.8 215.2-169.7 215.2zm143.7-146.3c-5.4-55.7-78.5-94-163.4-85.7-84.8 8.6-148.8 60.3-143.4 116s78.5 94 163.4 85.7c84.8-8.6 148.8-60.3 143.4-116zM347.9 35.1c-25.9 5.6-16.8 43.7 8.3 38.3 72.3-15.2 134.8 52.8 111.7 124-7.4 24.2 29.1 37 37.4 12 31.9-99.8-55.1-195.9-157.4-174.3zm-78.5 311c-17.1 38.8-66.8 60-109.1 46.3-40.8-13.1-58-53.4-40.3-89.7 17.7-35.4 63.1-55.4 103.4-45.1 42 10.8 63.1 50.2 46 88.5zm-86.3-30c-12.9-5.4-30 .3-38 12.9-8.3 12.9-4.3 28 8.6 34 13.1 6 30.8.3 39.1-12.9 8-13.1 3.7-28.3-9.7-34zm32.6-13.4c-5.1-1.7-11.4.6-14.3 5.4-2.9 5.1-1.4 10.6 3.7 12.9 5.1 2 11.7-.3 14.6-5.4 2.8-5.2 1.1-10.9-4-12.9z"/></svg>
                
              </span></a><a href="javascript:void(0)" onclick="showWeixinQR()"
          class="ananke-social-link weixin no-underline"
          title="Share on Weixin" aria-label="Share on Weixin"><span class="icon">
                <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 576 512"><!--! Font Awesome Free 6.6.0 by @fontawesome - https://fontawesome.com License - https://fontawesome.com/license/free (Icons: CC BY 4.0, Fonts: SIL OFL 1.1, Code: MIT License) Copyright 2024 Fonticons, Inc. --><path d="M385.2 167.6c6.4 0 12.6.3 18.8 1.1C387.4 90.3 303.3 32 207.7 32 100.5 32 13 104.8 13 197.4c0 53.4 29.3 97.5 77.9 131.6l-19.3 58.6 68-34.1c24.4 4.8 43.8 9.7 68.2 9.7 6.2 0 12.1-.3 18.3-.8-4-12.9-6.2-26.6-6.2-40.8-.1-84.9 72.9-154 165.3-154zm-104.5-52.9c14.5 0 24.2 9.7 24.2 24.4 0 14.5-9.7 24.2-24.2 24.2-14.8 0-29.3-9.7-29.3-24.2.1-14.7 14.6-24.4 29.3-24.4zm-136.4 48.6c-14.5 0-29.3-9.7-29.3-24.2 0-14.8 14.8-24.4 29.3-24.4 14.8 0 24.4 9.7 24.4 24.4 0 14.6-9.6 24.2-24.4 24.2zM563 319.4c0-77.9-77.9-141.3-165.4-141.3-92.7 0-165.4 63.4-165.4 141.3S305 460.7 397.6 460.7c19.3 0 38.9-5.1 58.6-9.9l53.4 29.3-14.8-48.6C534 402.1 563 363.2 563 319.4zm-219.1-24.5c-9.7 0-19.3-9.7-19.3-19.6 0-9.7 9.7-19.3 19.3-19.3 14.8 0 24.4 9.7 24.4 19.3 0 10-9.7 19.6-24.4 19.6zm107.1 0c-9.7 0-19.3-9.7-19.3-19.6 0-9.7 9.7-19.3 19.3-19.3 14.5 0 24.4 9.7 24.4 19.3.1 10-9.9 19.6-24.4 19.6z"/></svg>
                
              </span></a></div><h1 class="f1 athelas mt3 mb1">雷德·霍夫曼为AI抗癌初创公司募资2460万美元。</h1>
      
      <p class="tracked"><strong>AI News Assistant</strong>
      </p>
      
      
    </header>
    <div class="article-content nested-copy-line-height lh-copy serif f4 nested-links mid-gray pr4-l w-two-thirds-l"><h2 id="content">Content</h2>
<article>
## TL;DR
领英联合创始人里德·霍夫曼（Reid Hoffman）与癌症研究专家悉达多·穆克吉（Siddhartha Mukherjee）共同创立了人工智能癌症药物研发初创公司Manas AI，并成功筹集了2460万美元的种子资金，旨在利用AI加速抗癌药物的发现和开发过程。
<h3 id="引言">引言</h3>
<p>领英（LinkedIn）联合创始人、知名科技投资者里德·霍夫曼（Reid Hoffman）与普利策奖得主、著名癌症研究专家悉达多·穆克吉（Siddhartha Mukherjee）<sup id="fnref:1"><a href="#fn:1" class="footnote-ref" role="doc-noteref">1</a></sup> 联手，共同创立了一家名为Manas AI的人工智能药物发现初创公司。该公司已成功筹集2460万美元的种子资金<sup id="fnref:2"><a href="#fn:2" class="footnote-ref" role="doc-noteref">2</a></sup><sup id="fnref:3"><a href="#fn:3" class="footnote-ref" role="doc-noteref">3</a></sup>，旨在利用先进的人工智能技术，彻底改变癌症治疗药物的研发进程<sup id="fnref:4"><a href="#fn:4" class="footnote-ref" role="doc-noteref">4</a></sup><sup id="fnref:5"><a href="#fn:5" class="footnote-ref" role="doc-noteref">5</a></sup>。这一举措标志着AI在加速新药上市、为患者带来希望方面迈出了重要一步。</p>
<h3 id="manas-ai的成立与愿景">Manas AI的成立与愿景</h3>
<p>Manas AI的成立汇聚了科技投资界和医学研究领域的顶尖人才。霍夫曼作为硅谷的资深投资者，其愿景是利用人工智能的潜力，将药物发现过程从传统的数十年缩短至短短几年<sup id="fnref1:3"><a href="#fn:3" class="footnote-ref" role="doc-noteref">3</a></sup>。穆克吉是畅销书《万病之王：癌症传》（The Emperor of All Maladies）的作者，他在癌症研究领域拥有深厚的专业知识和经验，为公司的科学方向提供了坚实的基础<sup id="fnref1:1"><a href="#fn:1" class="footnote-ref" role="doc-noteref">1</a></sup><sup id="fnref1:4"><a href="#fn:4" class="footnote-ref" role="doc-noteref">4</a></sup>。</p>
<p>该公司的核心目标是利用AI设计新的分子，并在湿实验室中进行测试，以加速抗癌药物的开发<sup id="fnref2:3"><a href="#fn:3" class="footnote-ref" role="doc-noteref">3</a></sup><sup id="fnref2:4"><a href="#fn:4" class="footnote-ref" role="doc-noteref">4</a></sup>。通过这种方式，Manas AI致力于为癌症治疗精确设计分子，从而在AI驱动的医学领域产生重大影响<sup id="fnref3:3"><a href="#fn:3" class="footnote-ref" role="doc-noteref">3</a></sup>。</p>
<h3 id="资金注入与技术策略">资金注入与技术策略</h3>
<p>Manas AI的2460万美元种子资金由里德·霍夫曼本人、General Catalyst和Greylock Partners共同领投<sup id="fnref4:3"><a href="#fn:3" class="footnote-ref" role="doc-noteref">3</a></sup>。尽管这笔资金相比其他大型AI生物技术初创公司而言显得较为“适中”<sup id="fnref5:3"><a href="#fn:3" class="footnote-ref" role="doc-noteref">3</a></sup><sup id="fnref3:4"><a href="#fn:4" class="footnote-ref" role="doc-noteref">4</a></sup>，但Manas AI致力于通过创新模式提升其影响力。</p>
<p>在技术层面，Manas AI将利用微软的云计算平台Azure，并借助微软在人工智能领域的“深厚专业知识”来开发新型药物<sup id="fnref4:4"><a href="#fn:4" class="footnote-ref" role="doc-noteref">4</a></sup>。这种战略合作有望为Manas AI提供强大的计算能力和先进的AI工具，以支持其宏大的药物发现目标，从而有望将救命疗法更快地推向市场<sup id="fnref6:3"><a href="#fn:3" class="footnote-ref" role="doc-noteref">3</a></sup>。</p>
<h3 id="行业背景与影响">行业背景与影响</h3>
<p>Manas AI的启动是当前AI在医疗保健领域，特别是在药物发现方面应用日益增长趋势的一部分<sup id="fnref1:2"><a href="#fn:2" class="footnote-ref" role="doc-noteref">2</a></sup>。通过利用人工智能的力量，Manas AI旨在缩短将救命疗法带给患者的时间，使其比以往任何时候都更快<sup id="fnref7:3"><a href="#fn:3" class="footnote-ref" role="doc-noteref">3</a></sup>。霍夫曼表示，Manas AI的目标是将药物发现从一个长达十年的过程转变为一个只需几年就能完成的过程<sup id="fnref8:3"><a href="#fn:3" class="footnote-ref" role="doc-noteref">3</a></sup>。这一愿景如果实现，将对癌症治疗领域产生深远影响，有望加速更多创新疗法的问世，从而改善全球数百万癌症患者的生活。</p>
<h3 id="结论">结论</h3>
<p>里德·霍夫曼与悉达多·穆克吉共同创立Manas AI，标志着人工智能与癌症研究的深度融合。凭借2460万美元的初始资金和明确的加速药物发现的目标，Manas AI有望在抗癌药物研发领域带来突破性进展。尽管面临资金规模的挑战，但其创新模式和顶尖团队的结合，预示着未来AI在医疗领域将发挥越来越关键的作用，为攻克癌症等顽疾提供新的希望。</p>
<h2 id="references">References</h2>
</article>
<p><strong>主要关键词或标签：</strong> 人工智能, 癌症研究, 里德·霍夫曼, Manas AI, 药物发现, 生物技术, 悉达多·穆克吉</p>
<h2 id="tags">Tags</h2>
<p>#AI #Technology</p>
<hr>
<p><em>This article was automatically generated by AI News Assistant on 6/9/2025, 8:03:16 AM</em></p>
<div class="footnotes" role="doc-endnotes">
<hr>
<ol>
<li id="fn:1">
<p>2024年1月29日. &quot;<a href="https://www.wsj.com/tech/ai/manas-ai-drug-discovery-reid-hoffman-93a6c023">Reid Hoffman Raises $24.6 Million for AI Cancer-Research Startup</a>&quot;. The Wall Street Journal. 检索日期 2024年4月28日.&#160;<a href="#fnref:1" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a>&#160;<a href="#fnref1:1" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a></p>
</li>
<li id="fn:2">
<p>2024年1月29日. &quot;<a href="https://www.msn.com/en-us/money/technology/reid-hoffman-raises-246-million-for-ai-cancer-research-startup/ar-AA1xW0Q3">Reid Hoffman Raises $24.6 Million for AI Cancer Research Startup - MSN</a>&quot;. MSN. 检索日期 2024年4月28日.&#160;<a href="#fnref:2" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a>&#160;<a href="#fnref1:2" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a></p>
</li>
<li id="fn:3">
<p>2024年1月29日. &quot;<a href="https://analyticsindiamag.com/ai-news-updates/reid-hoffmans-manas-ai-raises-24-6-million/">Reid Hoffman's Manas AI Raises $24.6 Million - Analytics India Magazine</a>&quot;. Analytics India Magazine. 检索日期 2024年4月28日.&#160;<a href="#fnref:3" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a>&#160;<a href="#fnref1:3" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a>&#160;<a href="#fnref2:3" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a>&#160;<a href="#fnref3:3" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a>&#160;<a href="#fnref4:3" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a>&#160;<a href="#fnref5:3" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a>&#160;<a href="#fnref6:3" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a>&#160;<a href="#fnref7:3" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a>&#160;<a href="#fnref8:3" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a></p>
</li>
<li id="fn:4">
<p>2025年1月27日. &quot;<a href="https://techcrunch.com/2025/01/27/reid-hoffmans-manas-ai-raises-24-6m-a-fraction-of-other-ai-drug-discovery-startups/">Reid Hoffman's Manas AI raises $24.6M, a fraction of other AI drug ...</a>&quot;. TechCrunch. 检索日期 2024年4月28日.&#160;<a href="#fnref:4" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a>&#160;<a href="#fnref1:4" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a>&#160;<a href="#fnref2:4" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a>&#160;<a href="#fnref3:4" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a>&#160;<a href="#fnref4:4" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a></p>
</li>
<li id="fn:5">
<p>2025年1月27日. &quot;<a href="https://www.axios.com/pro/health-tech-deals/2025/01/27/reid-hoffman-led-manas-ai-nabs-25m-for-cancer-drug-discovery">Reid Hoffman-led Manas AI nabs $25M for cancer drug discovery</a>&quot;. Axios. 检索日期 2024年4月28日.&#160;<a href="#fnref:5" class="footnote-backref" role="doc-backlink">&#x21a9;&#xfe0e;</a></p>
</li>
</ol>
</div>
<ul class="pa0">
  
   <li class="list di">
     <a href="/tags/ai/" class="link f5 grow br-pill ba ph3 pv2 mb2 dib black sans-serif no-underline">AI</a>
   </li>
  
   <li class="list di">
     <a href="/tags/technology/" class="link f5 grow br-pill ba ph3 pv2 mb2 dib black sans-serif no-underline">Technology</a>
   </li>
  
</ul>
<div class="mt6 instapaper_ignoref">
      
      
      </div>
    </div>

    <aside class="w-30-l mt6-l">




  <div class="bg-light-gray pa3 nested-list-reset nested-copy-line-height nested-links">
    <p class="f5 b mb3" style="color: #666;">相关阅读</p>
    <ul class="pa0 list">
	   
	     <li  class="mb2">
          <a href="/insights/2025-06-09-article-445/">硅谷热捧中国制造AI模型</a>
        </li>
	    
	     <li  class="mb2">
          <a href="/insights/2025-06-09-article-444/">科技媒体电信行业盘点：市场观点</a>
        </li>
	    
	     <li  class="mb2">
          <a href="/insights/2025-06-09-article-443/">一文读懂中国DeepSeek AI</a>
        </li>
	    
	     <li  class="mb2">
          <a href="/insights/2025-06-08-article-442/">世界顶级设计师乔纳森·伊夫联手OpenAI “‘重塑’计算机”</a>
        </li>
	    
	     <li  class="mb2">
          <a href="/insights/2025-06-08-article-441/">关税不确定性下 英伟达营收逆势飙升</a>
        </li>
	    
	     <li  class="mb2">
          <a href="/insights/2025-06-08-article-440/">AI教父约书亚·本吉奥：最新AI模型误导用户</a>
        </li>
	    
	     <li  class="mb2">
          <a href="/insights/2025-06-08-article-439/">四大事务所争相研发人工智能产品审计</a>
        </li>
	    
	     <li  class="mb2">
          <a href="/insights/2025-06-08-article-438/">美国在“国家版OpenAI”中受益最大</a>
        </li>
	    
	     <li  class="mb2">
          <a href="/insights/2025-06-08-article-437/">Meta签署伊利诺伊州核电站20年购电协议</a>
        </li>
	    
	     <li  class="mb2">
          <a href="/insights/2025-06-08-article-436/">特朗普贸易战致苹果阿里在华AI上线推迟</a>
        </li>
	    
	     <li  class="mb2">
          <a href="/insights/2025-06-08-article-435/">硅谷：过度炒作压倒实际丰裕</a>
        </li>
	    
	     <li  class="mb2">
          <a href="/insights/2025-06-08-article-434/">中国监管机构拟放缓汽车自动驾驶功能推广</a>
        </li>
	    
	     <li  class="mb2">
          <a href="/insights/2025-06-08-article-433/">英伟达供应商SK海力士借AI热潮实现利润新高</a>
        </li>
	    
	     <li  class="mb2">
          <a href="/insights/2025-06-08-article-432/">Meta支出飙升：押注AI与数据中心建设</a>
        </li>
	    
	     <li  class="mb2">
          <a href="/insights/2025-06-08-article-431/">硅谷热捧国产AI模型</a>
        </li>
	    
    </ul>
</div>



<div class="bg-light-gray pa3 nested-list-reset nested-copy-line-height nested-links mt3">
  <p class="f5 b mb3" style="color: #666;">AI写作声明</p>
  <div class="f6 lh-copy" style="color: #777;">
    <p>本文由AI系统全流程生成，涵盖选题、资料整合与撰写。文章发布后由人工编辑进行核查。文末附有详细的[引用信息索引]，供您查证溯源。</p>
  </div>
</div></aside>

  </article>

    </main>
    <footer class="bg-black bottom-0 w-100 pa3" role="contentinfo">
  <div class="flex justify-between">
  <a class="f4 fw4 hover-white white-70 dn dib-ns pv2 ph3 no-underline" href="http://192.168.50.247:1313/" >
    &copy;  AI内参 2025 
  </a>
    <div><div class="ananke-socials"></div>
</div>
  </div>
</footer>

    <script src="/js/relative-time.js"></script>
  </body>
</html>
